Breaking the Blood-Tumor Barrier to Revolutionize Primary Brain Tumor Treatment Development

Time: 1:45 pm
day: Conference Day Two


  • Overcoming the treatment blockade presented by primary brain tumors surrounded by an intact blood-brain barrier
  • Reviewing lessons learned from brain tumor studies evaluating ability of drugs to cross the BBB
  • Exploring the promise of focused ultrasound to augment exposure of primary brain tumors to non-BBB penetrant anti-cancer compounds